Lam CSP, Ramasundarahettige C, Branch KRH, Sattar N, et al. Efpeglenatide and Clinical Outcomes with and without Concomitant Sodium-Glucose Co-Transporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial. Circulation 2021 Nov 14. doi: 10.1161/CIRCULATIONAHA.121.057934.
PMID: 34775781